Literature DB >> 33315226

Investigating Conformational Dynamics and Allostery in the p53 DNA-Binding Domain Using Molecular Simulations.

Elena Papaleo1.   

Abstract

The p53 tumor suppressor is a multifaceted context-dependent protein, which is involved in multiple cellular pathways, with the ability to either keep the cells alive or to kill them through mechanisms such as apoptosis. To complicate this picture, cancer cells that express mutant p53 becomes addicted to the mutant activity, so that the mutant variant features a myriad of gain-of-function activities, opening different venues for therapy. This makes essential to think outside the box and apply new approaches to the study of p53 structure-(mis)function relationship to find new critical components of its pathway or to understand how known parts are interconnected, compete, or cooperate. In this context, I will here illustrate how to integrate different computational methods to the identification of possible allosteric effects transmitted from the DNA binding interface of p53 to regions for cofactor recruitment. The protocol can be extended to any other cases of study. Indeed, it does not necessarily apply only to the study of DNA-induced effects, but more broadly to the investigation of long-range effects induced by a biological partner that binds to a biomolecule of interest.

Entities:  

Keywords:  Allostery; DNA-binding domain; Metadynamics; Molecular dynamics; Protein structure network; Structural communication; Transcription factor; p53

Mesh:

Substances:

Year:  2021        PMID: 33315226     DOI: 10.1007/978-1-0716-1154-8_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  108 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 2.  Blinded by the Light: The Growing Complexity of p53.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

Review 3.  The Paradox of p53: What, How, and Why?

Authors:  Yael Aylon; Moshe Oren
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

4.  p53: Multiple Facets of a Rubik's Cube.

Authors:  Yun Zhang; Guillermina Lozano
Journal:  Annu Rev Cancer Biol       Date:  2016-10-17

Review 5.  When mutants gain new powers: news from the mutant p53 field.

Authors:  Ran Brosh; Varda Rotter
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

Review 6.  TP53 mutations in human cancer: database reassessment and prospects for the next decade.

Authors:  Bernard Leroy; Martha Anderson; Thierry Soussi
Journal:  Hum Mutat       Date:  2014-06       Impact factor: 4.878

Review 7.  Limiting the power of p53 through the ubiquitin proteasome pathway.

Authors:  Vinod Pant; Guillermina Lozano
Journal:  Genes Dev       Date:  2014-08-15       Impact factor: 11.361

Review 8.  The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches.

Authors:  Andreas C Joerger; Alan R Fersht
Journal:  Annu Rev Biochem       Date:  2016-05-04       Impact factor: 23.643

9.  Mutational landscape and significance across 12 major cancer types.

Authors:  Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962

Review 10.  Census and evaluation of p53 target genes.

Authors:  M Fischer
Journal:  Oncogene       Date:  2017-03-13       Impact factor: 9.867

View more
  1 in total

Review 1.  DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy.

Authors:  Ruixue Huang; Ping-Kun Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-07-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.